Bioprocessing White Papers
Containment Solutions To Help Emerging Biologic Companies Get Products To The Market Faster
Gain solutions on how to set up your small company for long-term success using packaging containment offerings and services to help mitigate risks and speed up your time to market.
Build Your Genome Engineering Toolbox For Success
Fast, efficient, and precise options for genome engineering are rapidly infiltrating the marketplace – the key to success is identifying the mechanism and tool(s) best suited for your goals.
How To Improve Resiliency In The Medical Device Supply Chain
Explore how to select the right partner in the medical device supply industry to avoid supply chain breakdowns in product quality, delivery or availability that could endanger patient health.
A Risk-Based Approach To The Development Of An Injectable Combination Product
Examine how to establish a holistic approach to drug-device combination product (DDCP) development and how to assess and manage risk throughout the development and approval process.
Host Cell Protein Analysis: Immunoassays
Learn about Host cell proteins (HCPs) and the sensitive and specific orthogonal methods necessary to identify individual HCP impurities that persist through DS purification processes.
Cultivate Innovation And Growth At Smart, Connected Facilities
As the US and Europe continue to lead the way in addressing a growing demand for health care products, explore how the global biotechnology sector is maintaining momentum and confronting future challenges.
Reliable Osmolality Testing Of High Concentration mAb Formulations
Review an evaluation of the OsmoTECH XT (freezing point) and Vapro 5600 (vapor pressure) osmometers as a means of measuring concentrated protein formulations.
Orthogonal Methods To Understand And Define CQAs Of AAV Therapies
An essential part of AAV vector production is the characterization of potential CQAs. Learn about novel, robust, and orthogonal methods that can be used to assess identity, purity, and residuals.
Match Your Development And Manufacturing Path To Your IND Milestones
The drug development journey is long, expensive, resource straining, and risky. Discover how to maximize the value of early phase material and match your development path to your IND milestones.
Manufacturing Of Cytotoxic And Non-Cytotoxic Drugs In A Multiproduct Facility
The experience and expertise of the CMO is crucial to avoid the risk of cross-contamination of the drug product, as failures or weaknesses in this process can pose risk to the end-user.